Paroxysmal nocturnal haemoglobinuria with coexisting deficiency of the ninth component of complement: lack of massive haemolytic attack
- 1 January 1990
- journal article
- research article
- Published by Wiley in British Journal of Haematology
- Vol. 74 (1), 108-113
- https://doi.org/10.1111/j.1365-2141.1990.tb02546.x
Abstract
A 47-year-old woman with paroxysmal nocturnal haemoglobinuria (PNH) was found to have an inherited deficiency in the ninth complement component (C9). In complement-sensitivity lysis tests, 80% of her erythrocytes were markedly complement-sensitive (PNH-III). Laser cytofluorimetry with a monoclonal antibody against decay-accelerating factor (DAF) revealed that 95% of her erythrocytes were DAF-negative. Surprisingly, she has suffered only mild haemolysis and has never experienced massive spontaneous haemolysis. Gross haemoglobinuria and jaundice occurred only after receiving postoperative transfusions of whole blood. In her serum, C9 was not detectable either by immunological or by functional assays. Both the Ham test and the sugar water test using normal human serum or plasma yielded marked haemolysis of the patient''s erythrocytes. When the patient''s serum or plasma was used, only a trace of lysis was detected. Addition of purified human C9 to her plasma fully restored haemolysis. These observations indicated that C9 may play a critical role in haemolytic attacks in patients with PNH and that characteristic haemolysis in PNH may be tempered by coexisting C9 deficiency.This publication has 30 references indexed in Scilit:
- Characteristic mode of action of gangliosides in selective modulation of CD4 on human T lymphocytesBiochemical and Biophysical Research Communications, 1989
- The occurrence of precipitating antibodies in transfused Japanese patients with hereditary ninth component of complement deficiency and frequency of C9 deficiencyTransfusion, 1987
- Deficiency of the homologous restriction factor in paroxysmal nocturnal hemoglobinuria.The Journal of Experimental Medicine, 1987
- Release of decay-accelerating factor (DAF) from the cell membrane by phosphatidylinositol-specific phospholipase C (PIPLC). Selective modification of a complement regulatory protein.The Journal of Experimental Medicine, 1986
- Complement fixing abilities of IgA myeloma protiens and their fragments: The activation of complement through the classical pathwayImmunochemistry, 1976
- Determination of Serum C9 Level by ImmunodiffusionInternational Archives of Allergy and Immunology, 1975
- Variations in the Red Cells in Paroxysmal Nocturnal HaemoglobinuriaBritish Journal of Haematology, 1973
- MOLECULAR ANALYSIS OF THE MEMBRANE ATTACK MECHANISM OF COMPLEMENTThe Journal of Experimental Medicine, 1972
- Immune lysis of normal human and paroxysmal nocturnal hemoglobinuria (PNH) red blood cells. I. The sensitivity of PNH red cells to lysis by complement and specific antibody.Journal of Clinical Investigation, 1966
- COMPONENTS OF GUINEA PIG COMPLEMENTThe Journal of Experimental Medicine, 1963